Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY (DEFICIT)

v3.21.2
CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY (DEFICIT) - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Balance at the beginning at Dec. 31, 2019 $ 3 $ 48,670 $ (3,280) $ (75,415) $ (30,022)
Balance at the beginning (in shares) at Dec. 31, 2019 27,483,350        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss)       4,252 4,252
Foreign currency translation adjustments arising during the period     (1,870)   (1,870)
Balance at the end at Mar. 31, 2020 $ 3 48,670 (5,150) (71,163) (27,640)
Balance at the end (in shares) at Mar. 31, 2020 27,483,350,000        
Balance at the beginning at Dec. 31, 2019 $ 3 48,670 (3,280) (75,415) (30,022)
Balance at the beginning (in shares) at Dec. 31, 2019 27,483,350        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss)         22,673
Foreign currency translation adjustments arising during the period         (776)
Balance at the end at Sep. 30, 2020 $ 3 48,670 (4,056) (52,742) (8,125)
Balance at the end (in shares) at Sep. 30, 2020 27,483,350,000        
Balance at the beginning at Mar. 31, 2020 $ 3 48,670 (5,150) (71,163) (27,640)
Balance at the beginning (in shares) at Mar. 31, 2020 27,483,350,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss)       11,974 11,974
Foreign currency translation adjustments arising during the period     263   263
Balance at the end at Jun. 30, 2020 $ 3 48,670 (4,887) (59,189) (15,403)
Balance at the end (in shares) at Jun. 30, 2020 27,483,350,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss)       6,447 6,447
Foreign currency translation adjustments arising during the period     831   831
Balance at the end at Sep. 30, 2020 $ 3 48,670 (4,056) (52,742) (8,125)
Balance at the end (in shares) at Sep. 30, 2020 27,483,350,000        
Balance at the beginning at Dec. 31, 2020 $ 3 48,670 (2,860) (36,962) $ 8,851
Balance at the beginning (in shares) at Dec. 31, 2020 27,483,350       27,483,350
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss)       6,864 $ 6,864
Foreign currency translation adjustments arising during the period     284   284
Balance at the end at Mar. 31, 2021 $ 3 48,670 (2,576) (30,098) 15,999
Balance at the end (in shares) at Mar. 31, 2021 27,483,350        
Balance at the beginning at Dec. 31, 2020 $ 3 48,670 (2,860) (36,962) $ 8,851
Balance at the beginning (in shares) at Dec. 31, 2020 27,483,350       27,483,350
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss)         $ 8,373
Foreign currency translation adjustments arising during the period         23
Balance at the end at Sep. 30, 2021 $ 3 48,670 (2,747) (38,589) $ 7,337
Balance at the end (in shares) at Sep. 30, 2021 27,483,350       27,483,350
Balance at the beginning at Mar. 31, 2021 $ 3 48,670 (2,576) (30,098) $ 15,999
Balance at the beginning (in shares) at Mar. 31, 2021 27,483,350        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss)       6,815 6,815
Foreign currency translation adjustments arising during the period     254   254
Balance at the end at Jun. 30, 2021 $ 3 48,670 (2,322) (23,283) 23,068
Balance at the end (in shares) at Jun. 30, 2021 27,483,350        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss)       (5,306) (5,306)
Foreign currency translation adjustments arising during the period     (515)   (515)
Change in fair value of derivative instruments     90   90
Dividends declared       (10,000) (10,000)
Balance at the end at Sep. 30, 2021 $ 3 $ 48,670 $ (2,747) $ (38,589) $ 7,337
Balance at the end (in shares) at Sep. 30, 2021 27,483,350       27,483,350